Loading...

SOHO 2026 Annual Meeting

1,267 posters, 47 videos, 13 topics, 4 sessions, 853 authors

ePostersLive by SciGen Technologies S.A. All rights reserved.

SOHO 2026 Annual Meeting

September 9 - 12, 2026 | George R. Brown Convention Center, Houston, Texas

Poster Session

Thumbnail for Breaking BTK, Not Hearts: Cardiac Safety Review With Covalent and Noncovalent BTK Inhibitors

CLL - 1571

Breaking BTK, Not Hearts: Cardiac Safety Review With Covalent and Noncovalent BTK Inhibitors

Avantika Dhiman

Poster Presenter: Avantika Dhiman

Thumbnail for Real-World Treatment and Survival Outcomes for Zanubrutinib and Acalabrutinib Monotherapy Among Treatment-Naive Patients With Chronic Lymphocytic Leukemia in the United States

CLL - 160

Real-World Treatment and Survival Outcomes for Zanubrutinib and Acalabrutinib Monotherapy Among Treatment-Naive Patients With Chronic Lymphocytic Leukemia in the United States

Daniel A. Ermann

Poster Presenter: Daniel A. Ermann

Thumbnail for Risk of Therapy-Related Myeloid Neoplasms in Patients With Chronic Lymphocytic Leukemia Treated With BTK Inhibitors: A Retrospective Multicenter Analysis Using the TriNetX Database

CLL - 1623

Risk of Therapy-Related Myeloid Neoplasms in Patients With Chronic Lymphocytic Leukemia Treated With BTK Inhibitors: A Retrospective Multicenter Analysis Using the TriNetX Database

Amna Bint I Munir

Poster Presenter: Amna Bint I Munir

Thumbnail for Socioeconomic and Geographic Disparities in Survival Outcomes Among Patients with Hairy Cell Leukemia: A Population-Based Analysis of Two Decades

CLL - 1650

Socioeconomic and Geographic Disparities in Survival Outcomes Among Patients with Hairy Cell Leukemia: A Population-Based Analysis of Two Decades

Asfand Yar Cheema

Poster Presenter: Asfand Yar Cheema

Thumbnail for Real-World Impact of Atrial Fibrillation on Cardiovascular Outcomes and Healthcare Resource Utilization in Patients With Chronic Lymphocytic Leukemia

CLL - 169

Real-World Impact of Atrial Fibrillation on Cardiovascular Outcomes and Healthcare Resource Utilization in Patients With Chronic Lymphocytic Leukemia

G Rhys Williams

Poster Presenter: G Rhys Williams

Thumbnail for Real-World Comparison of Bleeding Outcomes Between Acalabrutinib and Zanubrutinib in Anticoagulated CLL Patients: A 6-Month and 1-Year Propensity-Matched Analysis Using the TriNetX Global Network

CLL - 1695

Real-World Comparison of Bleeding Outcomes Between Acalabrutinib and Zanubrutinib in Anticoagulated CLL Patients: A 6-Month and 1-Year Propensity-Matched Analysis Using the TriNetX Global Network

Ansy Patel

Poster Presenter: Ansy Patel

Thumbnail for Efficacy and Safety of Fixed-Duration Venetoclax-Based Therapy in Chronic Lymphocytic Leukemia: A Systematic Review and Meta-Analysis

CLL - 1709

Efficacy and Safety of Fixed-Duration Venetoclax-Based Therapy in Chronic Lymphocytic Leukemia: A Systematic Review and Meta-Analysis

anusree haridas

Poster Presenter: anusree haridas

Thumbnail for Global Macroeconomic Burden of Leukemia Attributable to Tobacco: A Value-of-Lost-Welfare Analysis Across 184 Countries

CLL - 1757

Global Macroeconomic Burden of Leukemia Attributable to Tobacco: A Value-of-Lost-Welfare Analysis Across 184 Countries

Kashish Magnani

Poster Presenter: Kashish Magnani

Thumbnail for Real-World Pharmacovigilance Assessment of Hematologic Safety Signals Among Bruton Tyrosine Kinase Inhibitors, Including Pirtobrutinib: Insights From the Food and Drug Administration Adverse Event Reporting System

CLL - 179

Real-World Pharmacovigilance Assessment of Hematologic Safety Signals Among Bruton Tyrosine Kinase Inhibitors, Including Pirtobrutinib: Insights From the Food and Drug Administration Adverse Event Reporting System

Klesta Cocoli

Poster Presenter: Klesta Cocoli